tiprankstipranks
ZyVersa Therapeutics (ZVSA)
NASDAQ:ZVSA
US Market

ZyVersa Therapeutics (ZVSA) Stock Forecast & Price Target

Compare
168 Followers
See the Price Targets and Ratings of:

ZVSA Financial Forecast

ZVSA Earnings Forecast

The previous quarter’s earnings for ZVSA were $1.79.
The previous quarter’s earnings for ZVSA were $1.79.
No data currently available

ZVSA Sales Forecast

The previous quarter’s earnings for ZVSA were $0.00.
The previous quarter’s earnings for ZVSA were $0.00.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright
$120
Buy
20238.98%
Upside
Reiterated
03/26/24
Buy Rating Affirmed: ZyVersa Therapeutics' Promising Pipeline and Strategic Advancements
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright
$120
Buy
20238.98%
Upside
Reiterated
03/26/24
Buy Rating Affirmed: ZyVersa Therapeutics' Promising Pipeline and Strategic Advancements
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

ZVSA Analyst Recommendation Trends

Rating
Dec 23
Feb 24
Mar 24
Nov 24
Jan 25
Strong Buy
4
4
6
5
4
Buy
0
0
0
0
0
Hold
0
0
0
0
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
4
6
5
5
In the current month, ZVSA has received 4 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. ZVSA average Analyst price target in the past 3 months is $20.00.
Each month's total comprises the sum of three months' worth of ratings.

ZVSA Stock Forecast FAQ

What is ZVSA’s average 12-month price target, according to analysts?
Based on analyst ratings, ZyVersa Therapeutics’s 12-month average price target is $20.00.
    What is ZVSA’s upside potential, based on the analysts’ average price target?
    ZyVersa Therapeutics has 3289.83% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ZVSA a Buy, Sell or Hold?
          ZyVersa Therapeutics has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is ZyVersa Therapeutics’s price target?
            The average price target for ZyVersa Therapeutics is $20.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $20.00 ,the lowest forecast is $20.00. The average price target represents 3289.83% Increase from the current price of $0.59.
              What do analysts say about ZyVersa Therapeutics?
              ZyVersa Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of ZVSA?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis